Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy
Advanced Science · 2026-06 · 13 (35)
DOI: 10.1002/advs.202515403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 12.01.2026. Verfasst von Jiajing Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Head and N…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Lactic Acid. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 283 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, International Orthodontics Foundation Young Research Grant.
Abstract (Originalsprache)
Lactate has evolved from being regarded as a byproduct of glycolysis to a pivotal regulator of cancer metabolism and signaling. The Warburg effect underscores how elevated lactate production meets the biosynthetic demands of highly proliferative cancer cells, while shaping an immunosuppressive tumor microenvironment (TME) that supports cancer growth and metastasis. The discovery of lactylation, a novel post‐translational modification, has further expanded the conceptual landscape, revealing how lactate serves as both a metabolite and a signaling molecule that couples metabolic reprogramming with gene regulation. This review delineates how lactate dynamically shuttles through the TME and boosts cancer malignancy, including proliferation, metastasis, drug resistance, and immune evasion. Also, this review integrates and discusses how lactate‐driven lactylation bridges metabolic and epigenetic control. Furthermore, emerging therapeutic strategies targeting lactate metabolism and lactylation are summarized, revealing their promise in cancer immunotherapy. Collectively, a comprehensive perspective is provided on the multifaceted roles of lactate and lactylation in cancer biology and, more importantly, highlights potential translational avenues for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University,…
- State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, S…
ORCID-Profile: Longjiang Li, Bo Li
Förderung
- National Natural Science Foundation of China
- International Orthodontics Foundation Young Research Grant
Zitieren
APA
Gong, J., Xie, Y., Weng, Z., Wu, Y., Li, L., & Li, B. (2026). Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy. Advanced Science, 13(35). https://doi.org/10.1002/advs.202515403
Vancouver
Gong J, Xie Y, Weng Z, Wu Y, Li L, Li B. Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy. Advanced Science. 2026;13(35). doi:10.1002/advs.202515403
BibTeX
@article{Gong2026,
author = {Gong, Jiajing and Xie, Yuhang and Weng, Zhijie and Wu, Yongzhi and Li, Longjiang and Li, Bo},
title = {Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {35},
doi = {10.1002/advs.202515403}
}
EUVIMED